The effect of influenza vaccination on risk of acute myocardial infarction: Self-controlled case-series study

Vaccine

Volumn 29, Issue 6, 2011, Pages 1145-1149

  Gwini, Stella M ^a   Coupland, Carol A C ^b   Siriwardena, Aloysius N ^c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

Influenza vaccination; Myocardial infarction; Self controlled case series design

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF CONTROLLED CASE SERIES DESIGN; STUDY DESIGN;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; VACCINATION;

EID: 78751572677     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.017     Document Type: Article

References (43)

1. Seto T.B., Mittleman M.A., Davis R.B., Taira D.A., Kawachi I. Seasonal variation in coronary artery disease mortality in Hawaii: observational study. BMJ 1998, 316:1946-1947.
2. The Eurowinter Group: Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. Lancet 1997, 349:1341-1346.
3. Woodhouse P.R., Khaw K.T., Plummer M., Foley A., Meade T.W. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994, 343:435-439.
4. Dobson A.J., Alexander H.M., Al-Roomi K., Gibberd R.W., Heller R.F., Leeder S.R., et al. Coronary events in the Hunter region of New South Wales, Australia: 1984-1986. Acta Med Scand Suppl 1988, 728:84-89.
5. Schanzer D.L., Langley J.M., Tam T.W. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. Vaccine 2008, 26:4697-4703.
6. Clayton T.C., Thompson M., Meade T.W. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008, 29:96-103.
7. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
8. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998, 351:1467-1471.
9. Spodick D.H., Flessas A.P., Johnson M.M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984, 53:481-482.
10. Steinvil A., Berliner S., Bromberg M., Cohen M., Shalev V., Shapira I., et al. Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis 2009, 206(1):270-275.
11. Kuanprasert S., Apichartpikul N., Chuenkitmongkol S., Wiangosot W., Topaiboon P., Sukonthasarn A. Evidence of influenza or influenza-like-illness preceding acute coronary syndrome. Southeast Asian J Trop Med Public Health 2008, 39:1040-1044.
12. Spodick D.H. Infection and infarction. Acute viral (and other) infection in the onset, pathogenesis, and mimicry of acute myocardial infarction. Am J Med 1986, 81:661-668.
13. Harskamp R.E., van Ginkel M.W. Acute respiratory tract infections: a potential trigger for the acute coronary syndrome. Ann Med 2008, 40:121-128.
14. Tofler G.H., Muller J.E. Triggering of acute cardiovascular disease and potential preventive strategies. Circulation 2006, 114:1863-1872.
15. Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000, 102:3039-3045.
16. Siscovick D.S., Raghunathan T.E., Lin D., Weinmann S., Arbogast P., Lemaitre R.N., et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000, 152:674-677.
17. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348:1322-1332.
18. Wang C.S., Wang S.T., Lai C.T., Lin L.J., Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007, 25:1196-1203.
19. Siriwardena A.N., Gwini S.M., Coupland C.A. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ 2010, 182:1617-1623.
20. Gurfinkel E.P., Leon de la F.R., Mendiz O., Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study. Eur Heart J 2004, 25:25-31.
21. Ciszewski A., Bilinska Z.T., Brydak L.B., Kepka C., Kruk M., Romanowska M., et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008, 29:1350-1358.
22. Jackson L.A., Yu O., Heckbert S.R., Psaty B.M., Malais D., Barlow W.E., et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002, 156:634-640.
23. Heffelfinger J.D., Heckbert S.R., Psaty B.M., Weiss N.S., Thompson W.W., Bridges C.B., et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006, 2:161-166.
24. Meyers D.G., Beahm D., Jurisich P.D., Milford C.J., Edlavich S. Influenza and pneumococcal vaccinations fail to prevent myocardial infarction. Heart Drug 2004, 4:96-100.
25. Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009, 9:601-610.
26. Whitaker H. The self controlled case series method. BMJ 2008, 337:a1069.
27. Walley T., Mantgani A. The UK General Practice Research Database. Lancet 1997, 350:1097-1099.
28. Jick H., Derby L.E., Gurewich V., Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 1996, 16:321-326.
29. Tata L.J., West J., Harrison T., Farrington P., Smith C., Hubbard R. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?. Thorax 2003, 58:835-839.
30. Musonda P., Farrington C.P., Whitaker H.J. Sample sizes for self-controlled case series studies. Stat Med 2006, 25:2618-2631.
31. Rastogi S., Gross P.A., Bonelli J., Dran S., Levandowski R.A., Russo C., et al. Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol 1995, 2:120-121.
32. Gross P.A., Russo C., Dran S., Cataruozolo P., Munk G., Lancey S.C. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 1997, 4:491-492.
33. Kunzel W., Glathe H., Engelmann H., Van H.C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996, 14:1108-1110.
34. Skowronski D.M., Tweed S.A., De S.G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 2008, 197:490-502.
35. Chodick G., Heymann A.D., Green M.S., Kokia E., Shalev V. Late influenza vaccination is associated with reduced effectiveness. Prev Med 2006, 43:71-76.
36. Hammad T.A., McAdams M.A., Feight A., Iyasu S., Dal Pan G.J. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2008, 17:1197-1201.
37. Spencer F.A., Goldberg R.J., Becker R.C., Gore J.M. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998, 31:1226-1233.
38. Govaert T.M., Sprenger M.J., Dinant G.J., Aretz K., Masurel N., Knottnerus J.A. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 1994, 12:1185-1189.
39. Bernstein E., Kaye D., Abrutyn E., Gross P., Dorfman M., Murasko D.M. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 1999, 17:82-94.
40. Leon de la F.R., Gurfinkel E.P., Toledo D., Mautner B. Flu vaccination in patients with acute coronary syndromes: treatment benefit in prespecified subgroups. Rev Esp Cardiol 2003, 56:949-954.
41. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008, 57:1-60.
42. Begg N.T., Salisbury D.M. Immunisation against infectious diseases 1996, HMSO, London, p. 167-172.
43. Department of Health The influenza immunisation programme 2008/09. CMO's letter PL/CMO/2008/3 2008, HMSO, London, p. 1-15.